CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 746,087 | ||
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 738,587 | ||
| 2024-10-28 | SEIDENBERG BETH C Director | Sale 10b5-1 | −14,798 | $48.01 | $710K | 131,755 |
| 2024-10-28 | SEIDENBERG BETH C Director | Sale 10b5-1 | −202 | $49.54 | $10K | 131,553 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +12,715 | $2.90 | $37K | 320,687 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −12,715 | $39.81 | $506K | 307,972 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +2,310 | $2.90 | $7K | 310,282 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −2,310 | $40.70 | $94K | 307,972 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +600 | $2.90 | $2K | 308,572 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −600 | $41.61 | $25K | 307,972 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +3,750 | $2.90 | $11K | 311,722 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −3,750 | $42.00 | $158K | 307,972 |
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 772,962 | ||
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 771,087 | ||
| 2024-10-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 769,212 | ||
| 2024-10-09 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +12,273 | $2.90 | $36K | 320,245 |
| 2024-10-09 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −12,273 | $38.08 | $467K | 307,972 |
| 2024-10-09 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +3,352 | $2.90 | $10K | 311,324 |
| 2024-10-09 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −3,352 | $38.83 | $130K | 307,972 |
| 2024-10-09 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 788,587 |
Page 10 of 17 · 321 trades